VV

Veena Viswanath

AB AbbVie: 9 patents #3 of 336Top 1%
📍 Irvine, CA: #20 of 1,054 inventorsTop 2%
🗺 California: #1,384 of 60,394 inventorsTop 3%
Overall (2017): #8,121 of 506,227Top 2%
9
Patents 2017

Issued Patents 2017

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9850264 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Richard L. Beard, John E. Donello 2017-12-26
9670150 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators Richard L. Beard, Tien T. Duong, John E. Donello, Michael E. Garst 2017-06-06
9670190 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators Richard L. Beard, John E. Donello, Michael E. Garst, Haiqing Yuan, Xiaoxia Liu 2017-06-06
9663457 Carbamoyl hydrazine derivatives as formyl peptide modulators Richard L. Beard, Vidyasagar Vuligonda, Thong Vu, John E. Donello 2017-05-30
9663460 Sulfur derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Michael E. Garst, John E. Donello, Xiaoxia Liu 2017-05-30
9603834 1,2- bis-sulfonamide derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Michael E. Garst, Xiaoxia Liu, John E. Donello 2017-03-28
9579307 Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Richard L. Beard, Tien T. Duong, John E. Donello, Michael E. Garst 2017-02-28
9550746 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, John E. Donello, Michael E. Garst 2017-01-24
9545394 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Daniel W. Gil, John E. Donello, Lauren M. Luhrs 2017-01-17